Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes

BODY_SITE - Body site where from sample was obtained (phv00167372.v1.p1)
ER Positive - Evidence of estrogen receptor expression on immunohistochemistry (phv00167364.v1.p1)
Expression Subtype - Expression subtype as determined by PAM50 classification (phv00167359.v1.p1)
Grade - Degree of tumor differentiation as determined by pathology (phv00167365.v1.p1)
HER 2 Positive - Evidence of her2 protein expression on immunohistochemistry (phv00167361.v1.p1)
Histology - Subtype as determined by pathology (phv00167366.v1.p1)
OSH Diagnosis - Outside hospital diagnosis as reported by the collaborator (phv00167369.v1.p1)
PR Positive - Evidence of progesterone receptor expression on immunohistochemistry (phv00167367.v1.p1)
Primary Disease - The main disease(s) for which the participant has been asked to donate a sample for study (phv00167358.v1.p1)
Stage - Pathological stage of breast cancer at diagnosis (phv00167363.v1.p1)

ANALYTE_TYPE - Molecular analyte (phv00167371.v1.p1)
CONSENT - Consent group as determined by DAC (phv00167351.v1.p1)
Country - Country where sample was collected (phv00167360.v1.p1)
SAMPID - De-identified sample ID (phv00167368.v1.p1)
SAMPID - Sample ID (phv00167353.v1.p1)
Sample Type - Indicates the Tumor / Normal status of a sample (phv00167370.v1.p1)
SAMPLE_USE - Sample use. SNP_Array: SNP genotypes obtained using standard or custom microarrays; WES_SRA: Whole exome sequencing data available through SRA; WGS_SRA: Whole genome sequencing data available through SRA; mRNA_Expression: Expression data for mRNA sample (phv00167354.v1.p1)
SUBJID - Unique participant Identifier (phv00167355.v1.p1)
SUBJID - Subject ID (phv00167352.v1.p1)
SUBJID - Subject ID (phv00167350.v1.p1)